J&J's Addiction Expert Slammed For Touting Screening Tools

Law360 (July 1, 2019, 11:05 PM EDT) -- A UCLA addiction expert called by Johnson & Johnson in Oklahoma's landmark opioid crisis trial testified Monday that doctors have effective screening tools they should use to identify patients with addiction risks, but faced tough cross-examination questions about whether he'd misrepresented the usefulness of such tools.

In the trial, which started in May and could run for weeks more, the state of Oklahoma is accusing drugmaker Johnson & Johnson of cultivating a crisis of addiction and death by pushing its opioid drugs via systemic and societal systems, like networks of doctors and sales representatives.

But University of California, Los Angeles professor of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS